ID
44759
Description
An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms; ODM derived from: https://clinicaltrials.gov/show/NCT00161044
Link
https://clinicaltrials.gov/show/NCT00161044
Keywords
Versions (3)
- 8/12/16 8/12/16 -
- 4/13/21 4/13/21 - Dr. rer. medic Philipp Neuhaus
- 11/17/21 11/17/21 -
Copyright Holder
University of Maryland, Baltimore
Uploaded on
November 17, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Chronic Schizophrenia NCT00161044
Eligibility Chronic Schizophrenia NCT00161044
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
hepatic, renal, pulmonary, endocrine, active peptic ulcer disease or cardiovascular disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0023895
- UMLS CUI [2]
- C0022658
- UMLS CUI [3]
- C0024115
- UMLS CUI [4]
- C0014130
- UMLS CUI [5,1]
- C0030920
- UMLS CUI [5,2]
- C0205177
- UMLS CUI [6]
- C0007222
Description
seizure disorder, head injury
Data type
boolean
Alias
- UMLS CUI [1]
- C0014544
- UMLS CUI [2]
- C0018674
Description
substance use disorder
Data type
boolean
Alias
- UMLS CUI [1]
- C0038586
Description
investigational drug
Data type
boolean
Alias
- UMLS CUI [1]
- C0013230
Description
adverse effects, pregnancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0877248
- UMLS CUI [2]
- C0032961
Similar models
Eligibility Chronic Schizophrenia NCT00161044
- StudyEvent: Eligibility
C0036341 (UMLS CUI [2])
C0040615 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2])
C0024115 (UMLS CUI [3])
C0014130 (UMLS CUI [4])
C0030920 (UMLS CUI [5,1])
C0205177 (UMLS CUI [5,2])
C0007222 (UMLS CUI [6])
C0018674 (UMLS CUI [2])
C0032961 (UMLS CUI [2])